I think that is basically right though it might over simplify the stem cell side of things a bit.
My understanding of where we are has been influenced by a recent paper by Lewis, Rubel, and Stone in Acoustics Today (
http://acousticstoday.org/regenerat...becca-m-lewis-edwin-w-rubel-jennifer-s-stone/).
For me, one of the key takeaways is "As discussed above, we now know several powerful genes or signaling pathways that, when manipulated in very young rodents, cause supporting cells to divide and form new hair cells. But these same manipulations have very little effect or even deleterious effects in mature rodents." I had not been aware of this, and it is something I will pay more attention to. My guess is that most pre-clinical work is done on young rodents. This may well be successful, but if it doesn't translate to older rodents, it may well be unlikely to work on older humans.
They make a number of other points:
- They discuss over expression of ATOH1 (e.g., the Genvec trial) and point out that in contrast to the promising earlier work "recent studies are less encouraging".
- They discuss inhibition of Notch signalling (something Audion and probably Decibel are working on) which shows promise though they point out that studies have come to conflicting conclusions about its effectiveness: "One study suggests that infusion of Notch inhibitors into live mice can promote supporting cells to convert into hair cells in the organ of Corti of adult mice after hair cell damage (Mizutari et al., 2013). However, another study clearly describes a precipitous loss of efficacy of Notch inhibitors to stimulate hair cell regeneration (Maass et al., 2015). Hopefully, these apparently conflicting interpretations of Notch inhibition will be resolved in future studies."
- for both of these approaches, they say "Although Atoh1 misexpression and/or Notch inhibition appears to encourage supporting cells to form hair cell-like cells in mature animals, neither treatment has a significant effect on supporting cell division. Therefore, as a therapy alone, either manipulation would likely deplete supporting cells, which would almost certainly reduce the function of the organ of Corti." Thus the concern is what are the consequences of a depleted population of supporting cells? This is unknown at present.
- They discuss the small molecule p27kip1 as a possibility to induce supporting cells to divide which could solve the problem of a depletion of supporting cells. I think Sound Pharmaceuticals is working with p27kip1.
- Promising new approaches include attempting to manipulate multiple pathways simultaneously (I posted a link to a paper that was working with Notch and Wnt a while back) or by attempting to recreate the dynamics of gene expression during development. The latter is likely to be much harder but more promising. This appears to be what was done to grow the "ear-in-a-dish". Doing this clinically seems very challenging at the present.
- There's less discussion of stem cells, but they do point out the challenge of transplanted stem cells surviving in the inner ear. An additional challenge with stem cells is the lack of inner ear stem cells and thus the need to guide iPSCs to become hair cells.
- Finally, the "Clinical Considerations" section is interesting. Here is most of it "For instance, we do not know how many hair cells of each type must be regenerated to adequately restore hearing in impaired individuals. Although we know that inner hair cells are critical, we can only guess how well they will restore hearing in the absence of outer hair cells. Many forms of hearing loss are caused by selective destruction of outer hair cells; regeneration of outer hair cells alone could be helpful in such patients. Furthermore, we lack the capability to accurately test which type of cells need repair in patients. This assessment requires development of more cell-specific and noninvasive diagnostic procedures. In addition, high-resolution imaging of the inner ear, enabling quantitative assessment of each cell type, would be very helpful and is currently under investigation." Thus, separate from the basic science side of things, exactly what is required for restored hearing is unknown at present. I think the need for non-invasive imaging and diagnostic procedures is key and is currently under investigated.
After reading the paper, I am a bit less optimistic about what is in the pipeline and perhaps a bit more realistic about what to expect. I'm hopeful that one of these approaches will show meaningful results but definitely not expecting a breakthrough any time soon.